IPO review: A subscription rate of 3.81 times is displayed when the Groww IPO wraps up its bidding. Because of previous IPO results, experts advise cautious investment. While Groww is a high-risk, high-reward retail investment opportunity, Pine Labs provides consistent profits in enterprise payments.
Today, November 7, the last day of bidding for the Groww IPO, seems to be drawing interest. The Groww IPO subscription status is 3.81 times as of midday. In the meantime, interest in the Pine Labs IPO, the newest player in the primary market, is steadily growing. Groww's IPO GMP is currently trading at ₹5, while Pine Labs' IPO GMP is likewise at ₹5.There are a lot of chances in the industry, according to experts, and more IPOs are expected. With a number of successful initial public offerings (IPOs) trading at significant discounts from their peak prices soon after their debut, the recent track record has been less than favorable. As a result, analysts encouraged investors to approach cautiously and refrain from being overly enthusiastic.
Regarding which IPO to invest in, Harshal Dasani, Business Head of INVasset PMS, stated that the Groww and Pine Labs IPOs represent two different themes in India's fintech development: retail investing versus enterprise payments.
Regarding which IPO to invest in, Harshal Dasani, Business Head of INVasset PMS, stated that the Groww and Pine Labs IPOs represent two different themes in India's fintech development: retail investing versus enterprise payments.
Pine Labs, which is estimated to be worth $3 billion, provides an attractive entrée into India's merchant and point-of-sale ecosystem, according to Dasani. Its ₹2,080 crore issuance, which has strong support from international investors, is concentrated on integrating digital lending and expanding throughout Southeast Asia.
According to Dasani, the company's revenue mix is diversified, margins are increasing, and valuation has returned to about half of its top in 2022, all of which are indicators of sensible pricing.
In the meantime, he claimed that Groww is a symbol of India's thriving retail investment narrative. With more than 8 crore active users and a profit turnaround in FY25, the platform is unquestionably the industry leader in digital broking.
According to Dasani, the company's revenue mix is diversified, margins are increasing, and valuation has returned to about half of its top in 2022, all of which are indicators of sensible pricing.
In the meantime, he claimed that Groww is a symbol of India's thriving retail investment narrative. With more than 8 crore active users and a profit turnaround in FY25, the platform is unquestionably the industry leader in digital broking.
However, Dasani added, "its IPO valuation near 40x earnings leaves limited headroom for error, especially as SEBI tightens derivative exposure and the industry faces rising competition."
From the perspective of portfolio allocation, he believes Groww is still a high-growth but high-valuation consumer technology company, while Pine Labs offers a more stable risk-reward through a payments and SaaS-linked strategy.
He continued, "Investors looking for a scalable fintech with more balanced upside may find Pine Labs relatively better positioned, whereas momentum-driven investors can look to Groww — provided they accept near-term volatility for long-term digital finance exposure."
Groww is the greatest option, according to Ya Wealth Director Anuj Gupta, who supports the Groww IPO.
From the perspective of portfolio allocation, he believes Groww is still a high-growth but high-valuation consumer technology company, while Pine Labs offers a more stable risk-reward through a payments and SaaS-linked strategy.
He continued, "Investors looking for a scalable fintech with more balanced upside may find Pine Labs relatively better positioned, whereas momentum-driven investors can look to Groww — provided they accept near-term volatility for long-term digital finance exposure."
Groww is the greatest option, according to Ya Wealth Director Anuj Gupta, who supports the Groww IPO.
According to Gupta, Groww has over 14.38 million active users, and its main rivals are Zerodha and Angel One. But during the last two years, Angel One's stock has dropped by around 29%, which is indicative of the broader difficulties the broking sector faces, especially in light of SEBI's continuing regulatory changes.
"The Groww brand is expanding, but GMP is only ₹14, which is not very aggressive." For listing gain, investors may subscribe to this IPO. The Groww IPO's primary goals are to finance company expansion, give current investors a way out, and increase the capital base of its subsidiaries, Gupta continued.
Let's examine the trends in the grey market premium (GMP):
"The Groww brand is expanding, but GMP is only ₹14, which is not very aggressive." For listing gain, investors may subscribe to this IPO. The Groww IPO's primary goals are to finance company expansion, give current investors a way out, and increase the capital base of its subsidiaries, Gupta continued.
Let's examine the trends in the grey market premium (GMP):
Today's Groww IPO GMP
The premium for the Groww IPO gray market is ₹5. The expected listing price of Groww is ₹105 per unit, which is 5% more than the IPO price of ₹100, taking into account the upper end of the IPO pricing band and the current premium in the grey market.
The gray market patterns over the past ten sessions indicate that Groww IPO GMP is decreasing and is expected to continue to decline. According to experts, the maximum GMP is ₹16.70, while the smallest GMP is ₹5.00.
The premium for the Groww IPO gray market is ₹5. The expected listing price of Groww is ₹105 per unit, which is 5% more than the IPO price of ₹100, taking into account the upper end of the IPO pricing band and the current premium in the grey market.
The gray market patterns over the past ten sessions indicate that Groww IPO GMP is decreasing and is expected to continue to decline. According to experts, the maximum GMP is ₹16.70, while the smallest GMP is ₹5.00.
Today's IPO GMP for Pine Labs
The IPO GMP for Pine Labs is ₹5. The expected listing price of Pine Labs is ₹226 per unit, which is 2.26% more than the IPO price of ₹221, taking into account the upper end of the IPO pricing band and the existing premium in the grey market.
Today's IPO GMP is moving downward and is expected to continue down based on the activities in the grey market during the last six sessions. According to experts, the highest GMP is recorded at ₹60, while the lowest GMP has reached ₹5.
Investors' willingness to pay more than the issue price is shown by the "grey market premium."
The IPO GMP for Pine Labs is ₹5. The expected listing price of Pine Labs is ₹226 per unit, which is 2.26% more than the IPO price of ₹221, taking into account the upper end of the IPO pricing band and the existing premium in the grey market.
Today's IPO GMP is moving downward and is expected to continue down based on the activities in the grey market during the last six sessions. According to experts, the highest GMP is recorded at ₹60, while the lowest GMP has reached ₹5.
Investors' willingness to pay more than the issue price is shown by the "grey market premium."
0 Comments